Published in Heart Vessels on March 30, 2011
Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia. Heart Vessels (2013) 0.79
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med (2004) 11.86
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA (2005) 9.81
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J (2006) 4.38
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation (2007) 4.24
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet (2004) 3.52
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med (2005) 3.34
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83
Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J (2003) 1.75
Coronary artery stents. JAMA (2000) 1.70
Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation (1995) 1.66
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv (2008) 1.49
Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol (2009) 1.46
Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes (2002) 1.14
Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. J Am Coll Cardiol (2007) 1.03
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine. Heart Vessels (2010) 1.00
Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A (2006) 0.96
Metal implants and surface reactions. Injury (1996) 0.85
Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. Heart Vessels (2009) 0.84
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. J Am Coll Cardiol (2005) 0.84
Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol (1999) 0.83
Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation (2005) 0.80
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroIntervention (2008) 0.79
The Titanium-NO Stent:results of a multicenter registry. EuroIntervention (2006) 0.78
Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med (2009) 0.78
Real world experience with the TITAN(R) stent: a 9-month follow-up report from The Titan PORI Registry. EuroIntervention (2006) 0.78
TITAN 2 Bio-Active Stent (BAS) with titanium-NO. EuroIntervention (2008) 0.78
Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol (2006) 0.75
Short- and long-term outcomes of the titanium-NO stent registry. Cardiovasc Revasc Med (2005) 0.75
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
Electrocardiographic changes of ST-elevation myocardial infarction in patients with complete occlusion of the left main trunk without collateral circulation: differential diagnosis and clinical considerations. J Electrocardiol (2012) 2.63
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol (2004) 2.30
Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J (2007) 2.21
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet (2012) 2.14
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol (2008) 2.11
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A (2013) 2.00
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood (2011) 1.98
The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention. J Am Coll Cardiol (2008) 1.97
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol (2008) 1.89
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood (2002) 1.86
Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob Agents Chemother (2009) 1.73
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol (2006) 1.72
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. Rheumatology (Oxford) (2011) 1.67
IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol (2010) 1.64
X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol (2005) 1.61
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis (2010) 1.58
Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys (2010) 1.58
[Clinical utilization of the coronary pressure wire]. Rev Esp Cardiol (2002) 1.56
Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. J Am Coll Cardiol (2010) 1.53
Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels. Clin Chem Lab Med (2013) 1.52
Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU Int (2012) 1.50
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial. J Invasive Cardiol (2012) 1.50
Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study. J Am Coll Cardiol (2005) 1.48
Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv (2008) 1.46
[Differences in the management and prognosis of patients with non-ST segment elevation acute coronary syndrome according to the department of initial admission]. Rev Esp Cardiol (2004) 1.44
[In-hospital and long-term mortality in women with acute myocardial infarction treated by primary angioplasty]. Rev Esp Cardiol (2006) 1.44
Percutaneous coronary intervention with rotational atherectomy for severely calcified unprotected left main: immediate and two-years follow-up results. Catheter Cardiovasc Interv (2012) 1.43
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. EuroIntervention (2012) 1.43
Wandering coronary stenoses: adrenaline-induced coronary artery spasm in a patient resuscitated from cardiac arrest. Catheter Cardiovasc Interv (2010) 1.42
Effectiveness of "direct" stenting without balloon predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS]). Am J Cardiol (2006) 1.41
[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes]. Rev Esp Cardiol (2007) 1.41
Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial. Circ Cardiovasc Interv (2010) 1.40
Redo percutaneous mitral valvuloplasty for mitral restenosis: a comparison with first procedure for de novo mitral stenosis. Kardiol Pol (2011) 1.39
Percutaneous mitral valvotomy versus closed surgical commissurotomy. Up to 15 years of follow-up of a prospective randomized study. J Cardiol (2008) 1.39
Early atropine is safer than conventional atropine administration in the elderly undergoing dobutamine stress echocardiography. Kardiol Pol (2010) 1.39
The combined pharmacological stress echocardiography protocol for predicting viability in territories supplied by coronary arteries at varying degrees of obstruction. Kardiol Pol (2010) 1.39
The modified Selvester QRS score: can we predict successful ST segment resolution in patients with myocardial infarction receiving fibrinolytic therapy? Cardiol J (2010) 1.39
The EXTREME registry: titanium-nitride-oxide coated stents in small coronary arteries. Catheter Cardiovasc Interv (2010) 1.39
[Direct Stenting without Predilation: a Single-Center Experience with 1,000 Lesions]. Rev Esp Cardiol (2002) 1.39
Influence of aortic regurgitation after TAVI on left ventricular filling pattern. Eur J Clin Invest (2015) 1.38
Prevalence and predictors of pulmonary hypertension in elderly patients with isolated diastolic heart failure. Kardiol Pol (2010) 1.38
[Influence of hospital type on treatment and prognosis in patients with non-ST elevation acute coronary syndrome]. Rev Esp Cardiol (2010) 1.37
Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation. Clin Cancer Res (2005) 1.31
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin Cancer Res (2005) 1.31
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Haematologica (2013) 1.19
Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features. Am J Surg Pathol (2007) 1.18
Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J (2004) 1.12
Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma (2010) 1.08
[Program of coronary angioplasty in acute myocardial infarction in the region of Murcia (Spain). APRIMUR Registry]. Rev Esp Cardiol (2002) 1.07
[Time intervals in primary angioplasty from onset of symptoms until restoration of blood flow]. Rev Esp Cardiol (2002) 1.07
[Short- and medium-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease in patients who are poor candidates for surgical revascularization]. Rev Esp Cardiol (2004) 1.07
ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford) (2011) 1.07
Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis. PLoS One (2011) 1.03
Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int J Cancer (2002) 1.02
Value of electrocardiographic algorithm based on "ups and downs" of ST in assessment of a culprit artery in evolving inferior wall acute myocardial infarction. Am J Cardiol (2004) 1.02
Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem (2005) 1.02
Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. Rheumatology (Oxford) (2009) 1.01
CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas. Blood (2002) 0.99
Cardiac rupture and tamponade during ventriculography. Int J Cardiol (2007) 0.97
Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins. Am J Physiol Cell Physiol (2003) 0.96
Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry. Catheter Cardiovasc Interv (2010) 0.95
Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. Int J Cardiol (2006) 0.95
HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. Arch Neurol (2009) 0.93
Inactivation of human and murine norovirus by high-pressure processing. Foodborne Pathog Dis (2010) 0.93
A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol (2003) 0.93
Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial. Eur Heart J (2004) 0.91
Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol (2008) 0.89
Patterns of management of congenital tracheal stenosis. J Pediatr Surg (2003) 0.88
Biological pathways contributing to organ-specific phenotype of brain metastatic cells. J Proteome Res (2008) 0.88
Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl Res (2008) 0.88
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy. Ann Hematol (2014) 0.88
Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronóstico de la Angina (PEPA). Medicine (Baltimore) (2002) 0.87
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med (2005) 0.87
Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. J Urol (2010) 0.87
Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes. Clin Cancer Res (2013) 0.86
A new in vivo screening paradigm to accelerate antimalarial drug discovery. PLoS One (2013) 0.86
Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes. Am J Physiol Gastrointest Liver Physiol (2002) 0.86
Right heart thrombus-in-transit with pulmonary embolism in a patient with primary hypercoagulable state. Cardiol J (2010) 0.86
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol (2013) 0.86
[Right versus left radial artery approach for coronary angiography. Differences observed and the learning curve]. Rev Esp Cardiol (2006) 0.85
Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors. Am J Pathol (2011) 0.85
New criteria based on ST changes in 12-lead surface ECG to detect proximal versus distal right coronary artery occlusion in a case of acute inferoposterior myocardial infarction. Ann Noninvasive Electrocardiol (2004) 0.85
Unusual presentation of acute coronary syndrome. Bilateral coronary dissection after car accident. Am J Emerg Med (2009) 0.84
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection. J Acquir Immune Defic Syndr (2007) 0.84
Association of the intergenic single-nucleotide polymorphism rs10865331 (2p15) with ankylosing spondylitis in a Spanish population. J Rheumatol (2010) 0.83
Routine invasive versus ischemia-guided strategy in patients with acute inferior ST-elevation myocardial infarction who received fibrinolytic therapy: a prospective randomized controlled pilot trial. J Invasive Cardiol (2011) 0.83
Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ Cardiovasc Interv (2013) 0.83
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. Chest (2008) 0.83
Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature. Ultrastruct Pathol (2002) 0.82
Right atrial wall hematoma following percutaneous mitral valvuloplasty. J Cardiol (2008) 0.82
[Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial]. Rev Esp Cardiol (2006) 0.82
A design framework to model retinas. Biosystems (2006) 0.82
Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity. Nucleic Acids Res (2003) 0.82
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol (2008) 0.82
Inactivation kinetics of spores of Bacillus cereus strains treated by a peracetic acid-based disinfectant at different concentrations and temperatures. Foodborne Pathog Dis (2012) 0.81